Compression Therapy Market Report 2026

The compression therapy market size has grown strongly in recent years. It will grow from $4.66 billion in 2025 to $5.1 billion in 2026 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to growing prevalence of varicose veins and CVI, increasing aging population, rising incidence of sedentary lifestyles, expansion of hospital-based vascular treatments, improved reimbursement for compression therapy.

The compression therapy market size is expected to see strong growth in the next few years. It will grow to $7.37 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to growth in home healthcare services, technological advancements in dynamic compression devices, rising adoption in lymphedema management, increasing focus on preventive vascular care, expansion in emerging healthcare markets. Major trends in the forecast period include rising adoption of compression therapy for chronic venous disorders, increasing use of home-based compression therapy solutions, growing demand for customized and patient-specific compression products, expansion of compression therapy in post-surgical and rehabilitation care, increasing awareness and early diagnosis of vascular disorders.

The increasing prevalence of chronic diseases is anticipated to drive the growth of the compression therapy market in the coming years. Chronic diseases, also referred to as non-communicable diseases (NCDs), are long-term health conditions that persist over time and typically progress gradually. The occurrence of symptoms such as diabetes, edema, ulcers, and circulatory disorders in many chronic conditions creates a need for compression therapy, prompting patients to seek such treatments. For example, in April 2024, Allergy UK, a UK-based national charity, reported that more than 21 million people in the UK are affected by allergies, which became the most frequently reported chronic health condition in 2022, and forecasts suggest that by 2026, half of Europe’s population will experience at least one allergy. Consequently, the rising prevalence of chronic diseases is fueling the growth of the compression therapy market.

Leading companies operating in the compression therapy market are focusing on the development of innovative products, such as pneumatic compression devices, to expand their customer base, increase sales, and boost revenue. Pneumatic compression devices are medical devices used to support the treatment of various circulatory and vascular conditions. For example, in September 2023, AIROS Medical Inc., a US-based medical equipment manufacturer, introduced the AIROS 6P sequential compression device. The AIROS 6P features a distinctive set of capabilities, including a Peristaltic Mode that delivers a wave-like inflation and deflation pattern preferred by physicians and lymphedema therapists, particularly for upper extremity treatment. In addition, the device includes an enhanced electrical rating that enables operation at 100-240 VAC, allowing for global use. It also incorporates a larger air pump to accommodate newer and larger garments required by certain lymphedema patients.

In October 2025, WRS Group, a US-based supplier of orthopedic recovery, cold therapy, and compression therapy solutions, acquired Avanos Medical’s US Game Ready orthopedic rental business for an undisclosed amount. Through this acquisition, WRS Group seeks to broaden its national presence in orthopedic recovery by incorporating a widely adopted cold-and-compression therapy platform that improves postoperative rehabilitation support for both patients and clinicians. The Game Ready orthopedic rental business is a US-based provider of cold and compression therapy systems used for injury recovery and postsurgical rehabilitation in healthcare and athletic environments.

Major companies operating in the compression therapy market are 3M Company, ArjoHuntleigh AB, Bio Compression Systems Inc., BSN Medical GmbH, Cardinal Health Inc., DJ Orthopedics Global Inc., Julius Zorn GmbH, medi GmbH & Co KG, Paul Hartmann AG, Sanyleg Srl, Sigvaris Management AG, Smith & Nephew plc, Tactile Systems Technology Inc., Thuasne SA, Bauerfeind AG, Essity AB, Kinetec SAS, Lympha Press International Inc., Medi USA, Optima Molliter Srl, ConvaTec Inc.

North America was the largest region in the compression therapy market in 2025. Europe was the second-largest market in the compression therapy market. The regions covered in the compression therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the compression therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the compression therapy market by increasing costs of imported medical textiles, electronic components, and compression pumps, affecting pricing and availability across hospitals and homecare settings. segments such as compression pumps and advanced dynamic therapy devices are most impacted, with asia-pacific and europe facing supply chain pressures due to manufacturing concentration. however, tariffs are encouraging local manufacturing, supplier diversification, and regional sourcing, supporting long-term market resilience and cost optimization strategies.

The compression therapy market research report is one of a series of new reports that provides compression therapy market statistics, including compression therapy industry global market size, regional shares, competitors with a compression therapy market share, detailed compression therapy market segments, market trends and opportunities, and any further data you may need to thrive in the compression therapy industry. This compression therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Compression therapy is a treatment method that helps improve blood circulation in the feet, ankles, and lower legs. It is effective in reducing discomfort and swelling caused by circulatory conditions such as chronic venous insufficiency and varicose veins.

The primary product types in the compression therapy market include compression pumps, compression stockings, compression bandages, and compression tapes. Compression pumps are used in both acute care settings, such as hospitals for short-term use, and chronic care settings, including long-term use at home or in extended care facilities. These pumps are designed to treat conditions such as venous insufficiency, lymphedema, or deep vein thrombosis and vary based on the compression cycle duration. Key technologies involved in compression therapy include static compression therapy and dynamic compression therapy. Compression therapy is used across multiple applications, including the treatment of varicose veins, deep vein thrombosis, lymphedema, leg ulcers, and other conditions.

The compression therapy market includes revenues earned by entities by relieving tight muscles, decreasing pain, and promote relaxation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.